← BIXT Overview

Bioxytran, Inc Liquidation Value Calculator

Bioxytran, Inc

Current Price: N/A

Loading calculator data...

Advanced: All 91 XBRL Tags

Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.

Balance Sheet

TagValueUnit
cash
Cash total $509,914 USD
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations total
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
$509,914 USD
liabilities_current
Liabilities Current total
LiabilitiesCurrent
$3.25M USD
liabilities_total
Liabilities total $3.25M USD
long_term_debt
Debt Instrument Face Amount total
DebtInstrumentFaceAmount
$1.08M USD
shares_outstanding
Common Stock Shares Outstanding total
CommonStockSharesOutstanding
108.1M shares
Unmapped Tags (83)
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
$849,636USD
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
$838USD
Additional Paid In Capital
AdditionalPaidInCapital
$18.30MUSD
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
$11,544USD
Assets
Assets
$658,552USD
Assets Current
AssetsCurrent
$513,465USD
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
$12.47MUSD
Cash FDIC Insured Amount
CashFDICInsuredAmount
$250,000USD
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
$0USD/shares
Common Stock Shares Authorized
CommonStockSharesAuthorized
$400.00Mshares
Common Stock Shares Issued
CommonStockSharesIssued
$108.15Mshares
Common Stock Value
CommonStockValue
$108,148USD
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
$805,000USD
Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
$1pure
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
$0USD/shares
Deferred Tax Assets Gross
DeferredTaxAssetsGross
$3.51MUSD
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
$16.70MUSD
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
$16.70MUSD
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
$3.51MUSD
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
$403,353USD
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
$31,422USD
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
$176,509USD
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
$145,087USD
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
$133,867USD
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
$658,552USD
Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
$114,534USD
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
$0USD/shares
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
$50.00Mshares
Preferred Stock Shares Issued
PreferredStockSharesIssued
$43.28Mshares
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
$43.28Mshares
Preferred Stock Value
PreferredStockValue
$43,284USD
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
$-21.04MUSD
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
$-2.59MUSD
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
$197,376USD
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
$504,760USD
Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
$170,399USD
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
$495,921USD
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
$216,701USD
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
$3,551USD
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
$1.05MUSD
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
$-23,091USD
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
$-526,455USD
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
$23,091USD
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
$438,986USD
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
$731,216USD
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
$292,230USD
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
$12,000USD
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
$15.38Mshares
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
$0USD/shares
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
$0USD/shares
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
$1pure
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
$0pure
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
$15.38Mshares
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
$16.68Mshares
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
$0USD/shares
Earnings Per Share Basic
EarningsPerShareBasic
$-0USD/shares
Earnings Per Share Diluted
EarningsPerShareDiluted
$-0USD/shares
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
$0pure
General And Administrative Expense
GeneralAndAdministrativeExpense
$648,229USD
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
$-2.12MUSD
Interest Expense Nonoperating
InterestExpenseNonoperating
$134,314USD
Net Income Loss
NetIncomeLoss
$-2.12MUSD
Nonoperating Income Expense
NonoperatingIncomeExpense
$-280,568USD
Operating Expenses
OperatingExpenses
$1.84MUSD
Operating Income Loss
OperatingIncomeLoss
$-1.84MUSD
Prepaid Expense Current
PrepaidExpenseCurrent
$3,551USD
Research And Development Expense
ResearchAndDevelopmentExpense
$454,000USD
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
$43,787USD
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
$412,521USD
Asset Impairment Charges
AssetImpairmentCharges
$0USD
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
$0USD/shares
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
$15.38Mshares
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
$15.38Mshares
Deposits
Deposits
$111,547USD
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
$-216,701USD
Operating Loss Carryforwards
OperatingLossCarryforwards
$2,870USD
Other Short Term Borrowings
OtherShortTermBorrowings
$50,000USD
Profit Loss
ProfitLoss
$-2.12MUSD
Share Price
SharePrice
$0USD/shares
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
$121,062USD
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
$438,986USD
AccruedPayrollTaxesCurrentAndNoncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
$941,890USD
ProceedsFromLoans
ProceedsFromLoans
$323,090USD

Showing balance sheet tags only. Liquidation analysis uses balance sheet data.

Comments